Fate Therapeutics Newsroom

Barclays Maintains Fate Therapeutics(FATE.US) With Buy Rating, Maintains Target Price $10

Futu NewsDec 11 17:31

BofA Securities Maintains Fate Therapeutics(FATE.US) With Hold Rating, Maintains Target Price $3

Futu NewsDec 10 18:35

Hold Rating for Fate Therapeutics Amid Incremental Progress in CD19 CAR-T Therapy Development

TipRanksDec 10 17:50

Analysts' Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), Veeva Systems (VEEV) and Alcon (ALC)

TipRanksDec 6 20:33

TD Cowen Maintains Fate Therapeutics(FATE.US) With Hold Rating

Futu NewsDec 6 20:33

Piper Sandler Maintains Fate Therapeutics(FATE.US) With Buy Rating, Maintains Target Price $6

Futu NewsDec 6 01:31

A Quick Look at Today's Ratings for Fate Therapeutics(FATE.US), With a Forecast Between $3 to $10

Futu NewsNov 19 21:01

Fate Therapeutics Analyst Ratings

BenzingaNov 19 17:40

Barclays Releases a Buy Rating on Fate Therapeutics (FATE)

TipRanksNov 19 16:55

A Quick Look at Today's Ratings for Fate Therapeutics(FATE.US), With a Forecast Between $5 to $6

Futu NewsNov 14 21:05

Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE), Mereo Biopharma Group Plc (MREO) and Fate Therapeutics (FATE)

TipRanksNov 14 15:44

A Quick Look at Today's Ratings for Fate Therapeutics(FATE.US), With a Forecast Between $5 to $10

Futu NewsNov 13 21:05

Analysts Conflicted on These Healthcare Names: McKesson (MCK), Fate Therapeutics (FATE) and Voyager Therapeutics (VYGR)

TipRanksNov 13 18:42

Fate Therapeutics Analyst Ratings

BenzingaNov 13 18:14

Fate Therapeutics (FATE) Receives a Buy From Barclays

TipRanksNov 13 18:14

TD Cowen Sticks to Its Hold Rating for Fate Therapeutics (FATE)

TipRanksNov 13 10:53

Fate Therapeutics Analyst Ratings

BenzingaAug 22 19:36

HC Wainwright & Co. Reiterates Neutral on Fate Therapeutics, Maintains $5 Price Target

BenzingaAug 22 19:35

H.C. Wainwright Maintains Fate Therapeutics(FATE.US) With Hold Rating, Maintains Target Price $5

Futu NewsAug 22 18:31

Fate Therapeutics: Hold Rating Amid Financial Stability and Upcoming Milestones

TipRanksAug 22 18:29